GT-02287 boosts enzyme activity in Parkinson’s brain: Trial data
GT-02287, an oral therapy being developed by Gain Therapeutics, can increase glucocerebrosidase (GCase) enzyme activity in the brains of…
Articles by Andrea Lobo
Grant backs new imaging approach for earlier Parkinson’s detection
The Michael J. Fox Foundation (MJFF) has awarded a $1 million research grant to MODAG to advance new…
Companies team on bringing Parkinson’s treatments to brain
Biotechnology company Ophidion is teaming up with Neuronasal, a clinical-stage company focused on nose-to-brain delivery of therapies for central…
Dosing begins in clinical trial of Parkinson’s cell therapy RNDP-001
Kenai Therapeutics said the first patient has been dosed in a Phase 1 clinical trial testing the safety and efficacy…
MJFF awards grants to advance 5 new targets for Parkinson’s drugs
Three research teams investigating five high-potential targets for new Parkinson’s disease therapies received initial funding under a multi-year initiative…
Solengepras significantly reduces off time for patients on levodopa
Solengepras, an experimental once-daily pill for Parkinson’s disease, significantly reduces the time patients spend with re-emerging…
Brain ‘short circuit’ behind Parkinson’s motor issues: Study
Dysfunctional nerve cells in the brain’s motor command center may be driving the rigid brain wave patterns associated with…
Parkinson’s disrupts key brain connections, PET scan study finds
People with Parkinson’s disease exhibit an interplay between the loss of dopamine-producing neurons and overall nerve…
Finding ways to make Parkinson’s hospital care more ‘age friendly’
The Parkinson’s Foundation has published a new journal article outlining a practical pathway for making hospital care more age friendly…
New global alliance unites platform trials to hasten Parkinson’s research
Cure Parkinson’s and France Parkinson have joined forces to launch a new international initiative, the Global Alliance for…